SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom ($AVGO) is trending amid discussions of its AI infrastructure role and upcoming earnings, with some traders seeing it as oversold and a buying opportunity. Community members are debating its valuation relative to peers like Nvidia, as well as its potential to reach new price targets. Recent news highlights analyst ratings and key partnerships driving positive sentiment.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

GOOG is trending as it hits new all-time highs, fueled by enthusiasm surrounding its Gemini 3 AI model and potential dominance in the AI space. Community members are actively discussing its valuation, market cap, and potential competition with other tech giants, with some pointing out its strong core business and AI capabilities. The stock's recent performance is leading to debates about whether it's overbought and due for a correction.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WRD is trending due to positive earnings reports and analysts recognizing its potential in the robotaxi sector, with a focus on L4 technology. The community is discussing the company's revenue growth, expansion into new markets like Abu Dhabi, and partnerships with Uber and Bosch. Optimism is building around the stock's long-term potential, with some eyeing it as a candidate for stock of the year.

Jelly-My-Jelly

JELLYJELLY is trending amid community excitement over potential price appreciation, with some comparing it to other successful runners. However, there are also concerns about the sustainability of the rally and reports of suspicious wallet activity, alongside short positions being taken. The coin, associated with the Solana network, has seen significant volatility and liquidations.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is surging amidst reports of a potential two-year extension of Obamacare subsidies, sparking excitement among traders who believe this could revitalize the company's ACA-driven model. Community members are actively discussing the implications of the subsidy extension on signups and pricing, despite analysts' concerns about the company's profitability. The news has triggered a sector rally, raising questions about whether this is a genuine turnaround or merely a politically-charged boost.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending downwards as investors react to the failed Alzheimer's trial for semaglutide, despite the company's claim that the trial was a long shot with limited expectations; the decline is exacerbated by concerns about increased competition and potential pricing pressures in the weight loss drug market, and some investors speculate about potential acquisitions as a strategy to regain market share, while others see the current price as a buying opportunity given the company's strong fundamentals and the anticipation of the oral Wegovy launch.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals ($ARWR) is trending due to recent positive developments, including analyst upgrades and licensing deals, particularly the Novartis collaboration for a preclinical Parkinson's therapy. The community is focused on the potential for upcoming catalysts, such as the PDUFA date for Plozasiran and data readouts from other pipeline candidates, to drive significant market cap growth. Discussions also involve comparisons to Alnylam's valuation and the competitive landscape with Ionis Pharmaceuticals.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Enthusiasm surrounds Alphabet as community members discuss Google's AI initiatives, particularly the Gemini 3 model, and Waymo's autonomous vehicle expansion. Some traders are rotating from other AI plays into GOOGL, while others debate whether the stock is overbought. Recent news of Berkshire Hathaway increasing its stake in Alphabet has added to the positive sentiment.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings is trending amid news of a $35 million strategic investment in Performance Drone Works (PDW), a combat robotics manufacturer, boosting the company's autonomous defense capabilities. The community is discussing the potential for increased production and revenue, as well as Ondas's expanding reach in the defense sector. Some are speculating about the impact of this investment on Ondas's growth trajectory and potential for further gains.

Abercrombie & Fitch Co. engages in the retail of apparel, personal care products, and accessories. The firm operates through following geographical segments: Americas, EMEA and APAC. The Americas segment includes operations in North America and South America. The EMEA segment includes operations in Europe, the Middle East and Africa. The APAC segment includes operations in the Asia-Pacific region, including Asia and Oceania. The company was founded by David Abercrombie in 1892 and is headquartered in New Albany, OH.

Abercrombie & Fitch Co. - Ordinary Shares - Class A

Abercrombie & Fitch Co.

Abercrombie & Fitch is trending due to upcoming earnings, with community members discussing potential outcomes and a possible short squeeze. Some traders are eyeing options strategies, while others are debating the impact of tariffs and recent analyst ratings on the stock's future performance. The community is closely watching for any signs of leaked earnings data.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ademi & Fruchter LLP Investigates Claims of Securities Fraud against DexCom, Inc.

Ademi & Fruchter LLP Investigates Claims of Securities Fraud against DexCom, Inc. Ademi & Fruchter LLP Investigates Claims of Securities Fraud against DexCom, Inc. PR Newswire MILWAUKEE, Nov. 24...

Swiss National Bank Increases Stake in DexCom, Inc. $DXCM

Swiss National Bank lifted its position in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 7.7% in the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned...

Investors in DexCom, Inc. Should Contact The Gross Law Firm Before December 26, 2025 to Discuss Your Rights - DXCM

Investors in DexCom, Inc. Should Contact The Gross Law Firm Before December 26, 2025 to Discuss Your Rights - DXCM Investors in DexCom, Inc. Should Contact The Gross Law Firm Before December 26, 2025...

DexCom, Inc. $DXCM Shares Sold by Mediolanum International Funds Ltd

Mediolanum International Funds Ltd cut its holdings in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 20.8% during the 2nd quarter, according to its most recent Form 13F filing with the...

DexCom, Inc. $DXCM Shares Purchased by DNB Asset Management AS

DNB Asset Management AS boosted its holdings in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) by 2.0% in the second quarter, according to its most recent filing with the Securities and Exchange...

DXCM Announcement: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (DXCM) Investors to Contact the Firm About Securities Fraud Class Action Lawsuit

DXCM Announcement: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (DXCM) Investors to Contact the Firm About Securities Fraud Class Action Lawsuit DXCM Announcement: Kessler Topaz Meltzer...

Bank Julius Baer & Co. Ltd Zurich Sells 8,697 Shares of DexCom, Inc. $DXCM

Bank Julius Baer & Co. Ltd Zurich cut its position in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 10.3% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 75,616...

Westfield Capital Management Co. LP Sells 67,505 Shares of DexCom, Inc. $DXCM

Westfield Capital Management Co. LP lowered its position in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 2.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with...

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December...

Eagle Health Investments LP Decreases Stock Position in DexCom, Inc. $DXCM

Eagle Health Investments LP lowered its position in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 23.3% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 273,821...

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Dexcom Inc

Buying

Holding

Selling or trimming

Watching from the sidelines

What are you doing with Alphabet ($GOOGL) stock as it hits fresh all-time highs?

DXCM
Dexcom Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest DXCM News

DXCMDexcom Inc